查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1832043

精准医疗市场规模、份额、趋势及预测（依产品、技术、应用、最终用户及地区），2025 年至 2033 年

Precision Medicine Market Size, Share, Trends and Forecast by Product, Technology, Application, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球精准医疗市场规模达821亿美元。展望未来， IMARC Group预计到2033年，精准医疗市场规模将达到1,794亿美元，2025-2033年期间的复合年增长率（CAGR）为8.63%。基因组学的重大进步、医疗个人化程度的提高、慢性病盛行率的上升、技术创新、研究投入的不断增加以及向更有效、更个人化治疗的转变，正在影响精准医疗产业的发展。

精准医疗市场趋势：

基因组学和生物资讯学的技术进步

推动精准医疗市场成长的最重要驱动力之一是基因组学和生物资讯学的快速发展。高通量定序技术使基因组定序速度更快、成本更低，使得基因组资讯在临床实务中广泛应用。这促进了基于个体基因组成的个人化治疗的发展。此外，生物资讯学将生物资料与统计分析和计算工具相结合，在解读基因组测序产生的海量资料方面发挥着至关重要的作用。这些技术进步为识别导致各种疾病的基因突变以及开发改善治疗效果的标靶疗法铺平了道路，从而提升了精准医疗的市场份额。

慢性病盛行率不断上升

全球癌症、糖尿病和心血管疾病 (CVD) 等慢性疾病的增加是精准医疗市场扩张的关键趋势之一。这些疾病是全球死亡和残疾的主要原因，给医疗保健系统带来了沉重的负担。精准医疗为治疗这些疾病提供了一种相当前景的方法，其标靶疗法基于每位患者独特的基因特征进行治疗。这种个人化方法不仅提高了治疗效果，还降低了药物不良反应的风险，从而改善了患者的治疗效果并降低了医疗成本。随着这些疾病的盛行率持续上升，对精准医疗方法的需求预计将持续成长，从而推动精准医疗市场的成长。

研发投入不断增加

精准医疗产业的研发投入是另一个重要的成长驱动因素。政府、私人实体和慈善机构正增加对精准医疗研发活动的资助，以发现新的治疗标靶并开发新的诊断工具和治疗方法。这项投资对于生物标记的持续发现、伴随诊断的开发以及个人化治疗的进展至关重要。此类资金支持正在推动研发创新，加速科学发现向临床应用的转化，从而促进精准医疗份额的成长。

朝向个人化医疗转变

随着对客製化治疗方案的需求不断增长以及对预防医学的日益重视，个人化医疗的趋势日益明显，这推动了精准医疗市场的成长。患者和医疗服务提供者越来越意识到个人化医疗的益处，例如提高治疗效果、最大限度地减少药物选择的反覆试验以及降低长期治疗成本。电子健康记录 (EHR) 与基因组资料的整合促进了这一转变，增强了根据个别特征量身定制医疗方案的能力。因此，对精准医疗解决方案的需求日益增长，预计将提升精准医疗的市场份额。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球精准医疗市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 耗材
  • 仪器
  • 服务

第七章：市场区隔：依技术

  • 大数据分析
  • 生物资讯学
  • 基因定序
  • 药物研发
  • 伴随诊断
  • 其他的

第 8 章：市场区隔：按应用

  • 肿瘤学
  • 中枢神经系统（CNS）
  • 免疫学
  • 呼吸内科
  • 感染
  • 其他的

第九章：市场区隔：依最终用户

  • 医院和诊所
  • 诊断中心
  • 製药和生物技术公司
  • 医疗保健 IT 公司
  • 其他的

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 11 章：SWOT 分析

第 12 章：价值链分析

第 13 章：波特五力分析

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AstraZeneca plc
    • Bayer AG
    • bioMerieux SA
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • F. Hoffmann-La Roche AG
    • Illumina Inc.
    • Laboratory Corporation of America Holdings
    • Merck KGaA
    • Novartis AG
    • Pfizer Inc.
    • Qiagen NV
    • Quest Diagnostics Incorporated
    • Thermo Fisher Scientific Inc.
Product Code: SR112025A4567

The global precision medicine market size reached USD 82.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 179.4 Billion by 2033, exhibiting a growth rate (CAGR) of 8.63% during 2025-2033. Significant advancements in genomics, increasing healthcare personalization, rising prevalence of chronic diseases, technological innovations, growing investment in research, and a shift towards more effective, tailored treatments are influencing the precision medicine industry.

Precision Medicine Market Trends:

Technological advancements in genomics and bioinformatics

One of the most significant drivers driving the precision medicine market growth is the rapid advancement in genomics and bioinformatics. High-throughput sequencing technologies have made genome sequencing faster and more affordable, enabling the widespread use of genomic information in clinical practice. This has led to the development of personalized treatments based on the genetic makeup of individuals. Moreover, bioinformatics, which combines biological data with statistical analysis and computational tools, plays a crucial role in interpreting the vast amounts of data generated by genomic sequencing. These technological advancements have paved the way for the identification of genetic mutations responsible for various diseases and the development of targeted therapies that improve treatment outcomes, boosting precision medicine market share.

Increasing prevalence of chronic diseases

The global increase in chronic diseases such as cancer, diabetes, and cardiovascular diseases (CVDs) is one of the crucial precision medicine market trends aiding in market expansion. These conditions are leading causes of death and disability worldwide, placing a significant burden on healthcare systems. Precision medicine offers a promising approach to managing these diseases, with targeted therapies designed to treat each patient's disease based on their unique genetic profile. This personalized approach not only improves the effectiveness of treatment but also reduces the risk of adverse drug reactions, thereby enhancing patient outcomes and reducing healthcare costs. As the prevalence of these diseases continues to rise, the demand for precision medicine approaches is expected to grow, driving the precision medicine market growth.

Growing investment in research and development

Investment in research and development (R&D) in the precision medicine industry is acting as another significant growth-inducing factor. Governments, private entities, and philanthropic organizations are increasingly funding R&D activities in precision medicine to uncover novel therapeutic targets and develop new diagnostic tools and treatments. This investment is crucial for the continuous discovery of biomarkers, the development of companion diagnostics, and the advancement of personalized therapies. Such financial support is fueling innovations in the pipeline and accelerating the translation of scientific discoveries into clinical applications, thereby fostering the growth of the precision medicine share.

Shift Towards Personalized Healthcare

The growing shift towards personalized healthcare, driven by the increasing demand for tailored treatment options and the rising emphasis on preventive medicine is bolstering the precision medicine market growth. Patients and healthcare providers are becoming more aware of the benefits of personalized medicine, such as improved treatment efficacy, minimized trial and error in drug selection, and reduced treatment costs in the long run. This shift is supported by the integration of electronic health records (EHRs) with genomic data, which enhances the ability to tailor medical treatment to individual characteristics. As a result, there is a growing demand for precision medicine solutions, which is expected to boost precision medicine market share.

Precision Medicine Industry Segmentation:

Breakup by Product:

  • Consumables
  • Instruments
  • Services

The growing demand for precision medicine consumables, driven by the recurring need for new reagents and assays in personalized treatment protocols to ensure ongoing precision in patient-specific diagnostic and therapeutic processes is influencing the precision medicine industry.

Besides this, the surge in demand for precision medicine instruments owing to their critical role in advanced diagnostics and therapeutic monitoring, facilitating high-precision, real-time data for personalized healthcare decisions is aiding in market expansion.

Concurrently, the increasing reliance on precision medicine services is fueled by the necessity for expert analysis, interpretation of complex genomic data, and the customization of therapy plans, enhancing the efficacy of personalized treatment strategies.

Breakup by Technology:

  • Big Data Analytics
  • Bioinformatics
  • Gene Sequencing
  • Drug Discovery
  • Companion Diagnostics
  • Others

Drug discovery holds the largest share in the market

The demand for precision medicine in drug discovery is mainly propelled by the necessity to develop more effective, safer medications tailored to individual genetic profiles. This approach leverages high-throughput genomic technologies and bioinformatics, enabling researchers to identify novel therapeutic targets and predict drug responses more accurately. It also facilitates the creation of targeted therapies that significantly improve patient outcomes, reduce adverse effects, and expedite the journey from laboratory research to clinical practice, thus creating a favorable outlook for market expansion.

In line with this, the integration of big data analytics in the healthcare sector for deciphering complex datasets, enabling predictive modeling and personalized treatment strategies is positively impacting the precision medicine industry.

Moreover, the rising demand for bioinformatics, essential in precision medicine for analyzing biological data, especially in understanding genetic variations, which facilitates personalized therapeutic strategies and enhances diagnostic accuracy is impelling the market growth.

In confluence with this, gene sequencing technology is fundamental in identifying genetic disorders and tailoring individualized treatments, which is contributing to its expanding demand in the development of precision medicine.

Additionally, the growing use of companion diagnostics for the effective implementation of precision medicine is aiding in market expansion, as they enable the identification of patients likely to benefit from specific treatments, ensuring targeted therapeutic approaches.

Apart from this, emerging technologies like clustered regularly interspaced short palindromic repeats (CRISPR) gene editing and AI-driven predictive models are propelling precision medicine by enabling groundbreaking personalized treatments and advancing our understanding of complex diseases.

Breakup by Application:

  • Oncology
  • Central Nervous System (CNS)
  • Immunology
  • Respiratory Medicine
  • Infections
  • Others

Oncology holds the largest share in the market

The demand for precision medicine in oncology is driven by its potential to revolutionize cancer treatment through personalized therapy. By understanding the genetic mutations and molecular characteristics of individual tumors, precision oncology allows for the development of targeted therapies that are more effective and have fewer side effects than traditional treatments. This tailored approach improves patient outcomes, enhances survival rates, and offers hope for those with previously untreatable cancers.

In addition to this, precision medicine also finds extensive applications in CNS disorders due to its potential to tailor treatments for neurological conditions, enhancing efficacy and reducing side effects tailored to individual genetic profiles.

Furthermore, immunology's growing reliance on precision medicine due to its ability to customize immune therapies, thereby improving treatment outcomes for autoimmune diseases by targeting patient-specific immunological pathways is fueling the market growth.

In confluence with this, the push for precision medicine in respiratory medicine for its capacity to personalize therapies for chronic respiratory diseases, optimizing treatment effectiveness and patient management based on individual genetic variations is fostering market expansion.

Moreover, the increasing demand in infections, driven by the precision medicine approach to develop targeted antimicrobial treatments to effectively combat antibiotic-resistant strains and tailored therapy based on the pathogen's genetic makeup is influencing market growth.

Besides this, precision medicine is also gaining traction for its ability to provide customized solutions across various medical fields, enhancing treatment precision, improving clinical outcomes, and offering novel therapeutic options tailored to individual patient profiles.

Breakup by End User:

  • Hospitals and Clinics
  • Diagnostic Centers
  • Pharma and Biotech Companies
  • Healthcare IT Firms
  • Others

Hospitals and clinics hold the largest share in the market

The demand for precision medicine in hospitals and clinics is escalating as these settings increasingly recognize its potential to significantly enhance patient care. By integrating individual genetic information, hospitals and clinics can offer more accurate diagnoses, effective treatments, and personalized care plans. This shift not only improves patient outcomes but also optimizes healthcare resources, reduces hospitalization rates, and tailors patient management, aligning with the evolving expectations of personalized healthcare.

Along with this, the growing need for precise, personalized diagnostic information to facilitate targeted treatment plans and improved patient outcomes is boosting the adoption of precision medicine approaches in diagnostic centers.

Moreover, pharma and biotech companies are increasingly investing in precision medicine to develop targeted therapies that offer higher efficacy and reduced risk, tailoring treatments to individual genetic profiles, which is further impelling the market growth.

In line with this, healthcare information technology (IT) firms play a pivotal role in advancing precision medicine, providing the data management and analytics capabilities essential for interpreting complex genomic data and supporting personalized healthcare solutions.

Other sectors, including research institutions and academic centers, are further boosting the demand for precision medicine by pioneering innovative approaches and technologies that enable personalized treatment strategies and advance the field of individualized care.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest precision medicine market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America's robust healthcare infrastructure, substantial investments in healthcare technology, and a strong emphasis on research and innovation are presenting lucrative opportunities for market expansion. The region's advanced regulatory framework supports the rapid adoption of personalized therapies, while the presence of leading biotech and pharmaceutical companies is fueling continuous advancements in precision medicine. Additionally, the presence of a well-informed population with increasing healthcare expectations is further providing an impetus to the market growth.

Besides this, the strong governmental support in Europe, extensive research collaborations, and well-established healthcare systems prioritizing personalized healthcare solutions and innovation in precision medicine are aiding in market expansion.

Concurrently, rapidly growing healthcare infrastructure, increasing investments in biotechnology, and rising awareness of personalized medicine's benefits are fueling the demand in the Asia Pacific region.

Furthermore, In Latin America, growing healthcare expenditure, increasing focus on research and development, and the rising prevalence of chronic diseases are boosting the adoption of precision medicine.

Apart from this, the demand in the Middle East and Africa is propelled by increasing healthcare investments, government initiatives to incorporate advanced healthcare technologies, and the rising demand for effective, personalized therapeutic approaches.

Leading Key Players in the Precision Medicine Industry:

The competitive landscape of the global precision medicine market is intensely dynamic and characterized by rapid technological advancements, strategic collaborations, and a strong focus on innovation. Major players in the field, including biotechnology firms, pharmaceutical giants, and healthcare IT companies, are continually expanding their product portfolios and enhancing their capabilities through research and development (R&D) investments, mergers and acquisitions, and partnerships with academic institutions and research organizations. These companies are competing fiercely to develop and commercialize precision medicine solutions that include advanced genomic analysis, biomarker detection, and personalized therapeutic interventions. The market is also witnessing a growing emphasis on regulatory compliance and the establishment of robust intellectual property rights, which are crucial for sustaining competitive advantage.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • AstraZeneca plc
  • Bayer AG
  • bioMerieux SA
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Illumina Inc.
  • Laboratory Corporation of America Holdings
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Qiagen N.V.
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1.How big is the precision medicine market?
  • 2.What is the future outlook for the precision medicine market?
  • 3.What are the key factors driving the precision medicine market?
  • 4.Which region accounts for the largest precision medicine market share?
  • 5.Which are the leading companies in the global precision medicine market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Precision Medicine Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Big Data Analytics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bioinformatics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Gene Sequencing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Drug Discovery
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Companion Diagnostics
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Central Nervous System (CNS)
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Immunology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Respiratory Medicine
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Infections
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diagnostic Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharma and Biotech Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Healthcare IT Firms
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AstraZeneca plc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bayer AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 bioMerieux SA
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Bristol-Myers Squibb Company
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Eli Lilly and Company
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 F. Hoffmann-La Roche AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 SWOT Analysis
    • 15.3.7 Illumina Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Laboratory Corporation of America Holdings
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Merck KGaA
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Novartis AG
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Pfizer Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Qiagen N.V.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Quest Diagnostics Incorporated
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis
    • 15.3.14 Thermo Fisher Scientific Inc.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials
      • 15.3.14.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Precision Medicine Market: Major Drivers and Challenges
  • Figure 2: Global: Precision Medicine Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Precision Medicine Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Precision Medicine Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Precision Medicine Market: Breakup by Technology (in %), 2024
  • Figure 6: Global: Precision Medicine Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Precision Medicine Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Precision Medicine Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Precision Medicine (Consumables) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Precision Medicine (Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Precision Medicine (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Precision Medicine (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Precision Medicine (Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Precision Medicine (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Precision Medicine (Big Data Analytics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Precision Medicine (Big Data Analytics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Precision Medicine (Bioinformatics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Precision Medicine (Bioinformatics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Precision Medicine (Gene Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Precision Medicine (Gene Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Precision Medicine (Drug Discovery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Precision Medicine (Drug Discovery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Precision Medicine (Companion Diagnostics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Precision Medicine (Companion Diagnostics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Precision Medicine (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Precision Medicine (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Precision Medicine (Oncology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Precision Medicine (Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Precision Medicine (Central Nervous System-CNS) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Precision Medicine (Central Nervous System-CNS) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Precision Medicine (Immunology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Precision Medicine (Immunology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Precision Medicine (Respiratory Medicine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Precision Medicine (Respiratory Medicine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Precision Medicine (Infections) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Precision Medicine (Infections) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Precision Medicine (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Precision Medicine (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Precision Medicine (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Precision Medicine (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Global: Precision Medicine (Diagnostic Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Global: Precision Medicine (Diagnostic Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Global: Precision Medicine (Pharma and Biotech Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Global: Precision Medicine (Pharma and Biotech Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Global: Precision Medicine (Healthcare IT Firms) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Global: Precision Medicine (Healthcare IT Firms) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Global: Precision Medicine (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Global: Precision Medicine (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: North America: Precision Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: North America: Precision Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: United States: Precision Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: United States: Precision Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Canada: Precision Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Canada: Precision Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Asia-Pacific: Precision Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Asia-Pacific: Precision Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: China: Precision Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: China: Precision Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Japan: Precision Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Japan: Precision Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: India: Precision Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: India: Precision Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: South Korea: Precision Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: South Korea: Precision Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Australia: Precision Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Australia: Precision Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Indonesia: Precision Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Indonesia: Precision Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Others: Precision Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Others: Precision Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Europe: Precision Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Europe: Precision Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Germany: Precision Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Germany: Precision Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: France: Precision Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: France: Precision Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: United Kingdom: Precision Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: United Kingdom: Precision Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Italy: Precision Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Italy: Precision Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Spain: Precision Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Spain: Precision Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Russia: Precision Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Russia: Precision Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Others: Precision Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Others: Precision Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Latin America: Precision Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Latin America: Precision Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Brazil: Precision Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 90: Brazil: Precision Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 91: Mexico: Precision Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 92: Mexico: Precision Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 93: Others: Precision Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 94: Others: Precision Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 95: Middle East and Africa: Precision Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 96: Middle East and Africa: Precision Medicine Market: Breakup by Country (in %), 2024
  • Figure 97: Middle East and Africa: Precision Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 98: Global: Precision Medicine Industry: SWOT Analysis
  • Figure 99: Global: Precision Medicine Industry: Value Chain Analysis
  • Figure 100: Global: Precision Medicine Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Precision Medicine Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Precision Medicine Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Precision Medicine Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 4: Global: Precision Medicine Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Precision Medicine Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Precision Medicine Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Precision Medicine Market: Competitive Structure
  • Table 8: Global: Precision Medicine Market: Key Players